Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of PDZD2 mRNA | decreases expression | 19933214
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PDZD2 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PDZD2 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of PDZD2 mRNA | decreases expression | 15761015
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PDZD2 mRNA | decreases expression | 19150397
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of PDZD2 mRNA | decreases expression | 15336504
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of PDZD2 mRNA | increases expression | 16002434
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of PDZD2 mRNA | affects cotreatment|increases expression | 17404688
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of PDZD2 mRNA | increases expression | 18035473
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of PDZD2 mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of PDZD2 mRNA | increases expression | 17404688
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PDZD2 mRNA | decreases expression | 19933214
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.50 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.50 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.57 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
9.43 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.43 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.56 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.43 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
1.97 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.97 | 12948864 17261762 17018787 19861407 18497071 16675129 14630087 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.97 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.48 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.66 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.70 | 14691202 15553829 16217749 15073043 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.70 | 16924424 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.09 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.25 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.66 | 11237771 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 16120746 18850075 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.73 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.73 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.73 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 15668235 8697196 16354765 15340226 12621046 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.35 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.51 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.51 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.19 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.24 | 15213294 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.54 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.67 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.82 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.82 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.51 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
9.85 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.85 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.07 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.37 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.37 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.57 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.57 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.43 | 15073043 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.12 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.42 | 16904648 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.40 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.07 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.25 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.97 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 16959395 18606429 8697196 16354765 15340226 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.95 | 18850075 18670907 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.58 | 15869954 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.74 | 17296493 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.74 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.74 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.05 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.66 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.76 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.76 | 15610895 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.89 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.93 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.50 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.53 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.90 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.16 | 16467208 17050201 19850784 20471514 16968895 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.30 | 9834237 12679006 15213294 17649720 16112521 11161223 19075265 19225113 17107899 17217047 15336539 17869043 17712046 16330433 19642359 15622746 16331271 16966277 12712474 16823087 19035177 15748426 12018890 16891316 11468182 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.51 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.30 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.30 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.68 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.68 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.68 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.29 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
10.29 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.29 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.46 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.33 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.33 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.35 | 16891317 11408345 17203775 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.35 | 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.70 | 19453300 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.20 | 19549372 14977855 19417148 11468182 15949261 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.89 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.22 | 16882451 16105982 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.39 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.05 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.12 | 16624393 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.93 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.01 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.01 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.20 | 10525206 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.56 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
8.13 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.13 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
8.13 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.57 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.31 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11118676 11399792 11896295 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.97 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.02 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.57 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.57 | 16644109 16289102 15754350 12479363 18247401 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.57 | 16740699 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.90 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.12 | 16646077 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.62 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.79 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.79 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.47 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.19 | 19014326 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.90 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.15 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.25 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.25 | 12973940 20435036 11780464 12845720 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.51 | 10091137 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |